SightfileU.S. market data from official filings

Companies › ANGO

ANGIODYNAMICS INC (ANGO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001275187 · EDGAR filings · Updated 2026-07-24

ANGIODYNAMICS INC (ANGO) has reported institutional ownership of 93.2%, with 146 institutional managers holding positions valued at $437.4M per the latest 13F reporting period.

Institutional ownership
93.2%
Institutional managers
146
Reported 13F value
$437.4M
Insider activity
32 trans.
$239.5K net buying

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ANGIODYNAMICS INC has 146 institutional holders and institutional ownership of 93.2%.

Insider activity

Insiders reported 32 transactions (3 buys, 0 sells) across 13 reporting insiders, with a net reported value of $239.5K.

Related companies

ALLOGENE THERAPEUTICS INC (ALLO) · MANNKIND CORP (MNKD) · ETON PHARMACEUTICALS INC (ETON) · ABCELLERA BIOLOGICS INC (ABCL) · DBV TECHNOLOGIES S A (DBVT) · VERASTEM INC (VSTM)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.